Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors

Photochemistry and Photobiology

Volumn 74, Issue 5, 2001, Pages 712-720

  Cecic, Ivana ^a   Parkins, Charles S ^b   Korbelik, Mladen ^a,c  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

^c BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; L SELECTIN; PHOTOFRIN; TEMOPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL ACTIVITY; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; DRUG EFFECT; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; LEUKOCYTE MOTILITY; MOUSE; NEUTROPHIL; NEUTROPHILIA; NONHUMAN; PERIPHERAL CIRCULATION; PHOTODYNAMIC THERAPY; SOLID TUMOR; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE MARROW; CARCINOMA, SQUAMOUS CELL; COMPLEMENT SYSTEM PROTEINS; DIHEMATOPORPHYRIN ETHER; KINETICS; L-SELECTIN; LEUKOCYTE COUNT; LUNG; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; NEUTROPHILS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; TIME FACTORS;

ANIMALIA; MYCOBACTERIUM BOVIS BCG;

EID: 0035526555     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2001)074<0712:IOSNRI>2.0.CO;2     Document Type: Article

References (46)

1. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905.
2. Korbelik, M., I. Cecic and J. Sun (2001) Relevance of PDT-induced inflammatory response for the outcome of photodynamic therapy. Proc, SPIE 4257, 19-24.
3. Fingar, V. H. (1996) Vascular effects of photodynamic therapy. J. Clin. Laser Med. Surg. 14, 323-328.
4. Henderson, B. W. and T. J. Dougherty (1992) How does photodynamic therapy work? Photochem. Photobiol. 55, 145-157.
5. Korbelik, M. (1999) Antitumor immune reaction elicited by photodynamic therapy. Proc. SPIE 3601, 68-74.
6. Krosl, G., M. Korbelik and G. J. Dougherty (1995) Induction of immune cell infiltration into murine SCCVII tumor by Photofrin-based photodynamic therapy. Br. J. Cancer 71, 549-555.
7. Gollnick, S. O., X. Liu, B. Owczarczak, D. A. Musser and B. W. Henderson (1997) Altered expression of Interleukin 6 and Interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. 57, 3904-3909.
8. Korbelik, M. (1996) Induction of tumor immunity by photodynamic therapy. J. Clin. Laser Med. Surg. 14, 329-334.
9. Korbelik, M. and I. Cecic (1999) Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Lett. 137, 91-98.
10. de Vree, W. J. A., M. C. Essers, H. S. de Brujin, W. M. Star, J. F. Koster and W. Sluiter (1996) Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res. 56, 2908-2911.
11. Weiss, S. J. (1989) Tissue destruction by neutrophils. N. Engl. J. Med. 320, 365-376.
12. Lichtenstein, A. and J. Kahle (1985) Anti-tumor effect of inflammatory neutrophils: characteristics of in vivo generation and in vitro tumor cell lysis. Int. J. Cancer 35, 121-127.
13. Vadas, M. A., N. A. Nicola and D. Metcalf (1983) Activation of antibody-dependent cell mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. J. Immunol. 130, 795-799.
14. MacPherson, G. G. and R. J. North (1986) Endotoxin-mediated necrosis and regression of established tumors in the mouse. A correlative study of quantitative changes in blood flow and ultrastructural morphology. Cancer Immunol. Immunother. 21, 209-216.
15. Colombo, M. P., L. Lombardi, A. Stoppacciaro, C. Milani, M. Parenza, B. Bottazi and G. Parmiani (1992) Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. J. Immunol. 149, 113-119.
16. Katano, M. and M. Torisu (1982) Neutrophil-mediated tumor cell destruction in cancer ascites. Cancer 50, 62-68.
17. Lloyd, A. R. and J. J. Oppenheim (1993) Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol. Today 13, 169-172.
18. Cassatella, M. A. (1999) Neutrophil-derived proteins: selling cytokines by the pound. Adv. Immunol. 73, 369-509.
19. Malech, H. L. and J. I. Gallin (1988) Current concepts: immunology. Neutrophils in human disease. N. Engl. J. Med. 317, 687-694.
20. Collard, C. D., R. Lekowski, J. E. Jordan, A. Agah and G. L. Stahl (1999) Complement activation following oxidative stress. Mol. Immunol. 36, 941-948.
21. Rockwell, S. C., R. F. Kallman and L. F. Fajardo (1972) Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J. Natl. Cancer Inst. 49, 735-749.
22. Suit, H. D., R. S. Sedlacek, G. Silver and D. Dosoretz (1985) Pentobarbital anesthesia and the response of tumor and normal tissue in the C3Hf/Sed mouse to radiation. Radiat. Res. 104, 47-65.
23. Korbelik, M. (1993) Distribution of disulfonated and tetrasulfonated aluminum phthalocyanine between malignant and host cell populations of a murine fibrosarcoma. J. Photochem. Photobiol. B: Biol. 20, 173-181.
24. Korbelik, M., J. Sun and J. J. Posakony (2001) Interaction between photodynamic therapy and BCG immunotherapy responsible for the reduced recurrence of treated mouse tumors. Photochem. Photobiol. 73, 403-409.
25. Etievant, M., B, Leluc and B. David (1988) In vitro inhibition of the classical and alternate pathways of activation of human complement by N acetyl aspartyl glutamic acid (NAAGA). Agents Actions 24, 137-144.
26. Morgan, P. (2000) Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates. In Methods in Molecular Biology, Vol. 150: Complement Methods and Protocols (Edited by P. Morgan), pp. 61-72. Humana Press Inc., Totowa, NJ.
27. Korbelik, M. and G. Krosl (1996) Photofrin accumulation in malignant and host cell populations of various tumours. Br. J. Cancer 73, 506-513.
28. Jyväsjärvi, S., S. Keinänen and O. Ruuskanen (1971) Leukocytosis in the mouse induced by serial blood sampling from the tail. Nat. (Lond.) 230, 122-123.
29. Sluiter, W., E. Hulsing-Hesselink, I. Elzenga-Claasen and R. van Furth (1985) Method to select mice in the steady state for biological studies. J. Immunol. Methods 760, 135-143.
30. Claman, H. N. (1972) Corticosteroids and lymphoid cells. N. Engl. J. Med. 287, 388-397.
31. Korbelik, M. and I. Cecic (1998) Enhancement of tumor response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment. J. Photochem. Photobiol. B: Biol. 44, 151-158.
32. van Eeden, S., R. Miyagashima, L. Haley and H. C. Hogg (1995) L-selectin expression increases on peripheral blood polymorphonuclear leukocytes during acute marrow release. Am. J. Respir. Crit. Care Med. 151, 500-507.
33. Kishimoto, T. K., M. A. Jutila, E. L. Berg and E. C. Butcher (1989) Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245, 1238-1241.
34. Burns, A. R. and C. M. Doerschuk (1994) Quantitation of L-selectin and CD18 expression on rabbit neutrophils during CD18-independent and CD18-dependent emigration in the lung. J. Immunol. 153, 3177-3188.
35. Kubo, H., N. A. Doyle, L. Graham, S. D. Bhagwan, W. M. Quinlan and C. M. Doerschuk (1999) L- and P-selectin and CD11/CD18 in intracapillary neutrophil sequestration in rabbit lungs. Am. J. Respir. Crit. Care Med. 159, 267-274.
36. Terashima, T., B. Wiggs, D. English, J. C. Hogg and S. F. van Eeden (1996) Polymorphonuclear leukocyte transit times in bone marrow during streptococcal pneumonia. Am. J. Physiol. 271, L587-L592.
37. Klebanoff, S. J. (1988) Phagocytic cells: products of oxygen metabolism. In Inflammation: Basic Principles and Clinical Correlations, (Edited by J. I. Gallin, I. M. Goldstein and R. Snyderman), pp. 391-444. Raven Press, New York.
38. Kampschmidt, R. F. and H. F. Upchurch (1980) Neutrophil release after injections of endotoxin or leukocyte endogenous mediator into rats. J. Reticuloendothel. Soc. 28, 191-201.
39. Kajita, T. and T. E. Hugli (1990) C5a-induced neutrophilia. A primary humoral mechanism for recruitment of neutrophils. Am. J. Pathol. 137, 467-477.
40. Ulich, T. R., J. del Castillo, M. Keys, G. A. Granger and R. X. Ni (1987) Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-α-induced changes in circulating numbers of neutrophils and lymphocytes. J. Immunol. 139, 3406-3415.
41. Kamide, R., I. Gigli and H. W. Lim (1984) Participation of mast cells and complement in the immediate phase of hematoporphyrin-induced phototoxicity. J. Investig. Dermatol. 82, 485-490.
42. Liaw, L.-H. L., J. S. Nelson, R. S. Steubing, G. P. Lim and M. W. Berns (1991) Complement activation during tumor photodynamic therapy. In International Conference on Photodynamic Therapy and Laser Medicine, Beijing, 15-17 October (Abstract L100).
43. Boggs, D. R. (1967) The kinetics of neutrophilic leukocytes in health and in disease. Semin. Hematol. 4, 359-387.
44. Oehler, L., O. Majdic, W. F. Pickl, J. Stockl, E. Riedl, J. Drach, K. Rappersberger, K. Geissler and W. Knapp (1998) Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics. J. Exp. Med. 187, 1019-1028.
45. Bainton, D. F. (1992) Developmental Biology of Neutrophils and Eosinophils, 2nd ed. Raven Press, New York.
46. de Vree, W. J. A., M. C. Essers, J. F. Koster and W. Sluiter (1997) Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors. Cancer Res. 57, 2555-2558.